UTREGLUTIDE GL0034
I-Sec upgrades Sun Pharma to Buy, target price Rs 1,895ICICI Securities has upgraded Sun Pharmaceutical Industries to 'Buy' with a revised target price of Rs 1895. Sun Pharma, a leading company ...
Sun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip ShanghviSun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes drug Utreglutid...
- Load More